Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Sissel Due Jensen

Biographic Data

ID2513355
NAMESissel Due Jensen
GIVEN NAMESSissel Due
FAMILY NAMEJensen
SIGNATUREJENSEN S D
AFFILIATIONSAarhus University Hospital
ORCID0000-0002-3420-9692
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Beyond the prescription

    Open Access•Sissel Due Jensen, Bruno Gualano et al.•ARTICLE•PLOS Global Public Health•2025

    Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are transforming medicine globally. Given the efficacy and the demand for these drugs for weight loss, significant and complex social implications will follow. Drawing on our current qualitative studies with users in Brazil, Denmark, Japan, the United States, and online communities, alongside our pre-GLP-1RA studies in ten additional countries, we identify nine emerging global trends. These inc…

  • Tinkering with weight loss medication in clinical encounters

    Open Access•Sissel Due Jensen, Annelli Sandbæk et al.•ARTICLE•Social Science & Medicine•2025•References: 26

    The introduction of semaglutide, a glucagon-like-1 receptor agonist (GLP-1ra) as a weight-loss medication, has attracted considerable public and medical attention, reporting weight reductions of up to 15 %. However, its rapid adoption highlights the growing entanglement of the pharmaceutical industry, public health agendas, and cultural body ideals. This development calls for a closer examination of how such medications impact medical practices, …

  • Digitally Connecting Health Care Providers to Integrate Chronic Care

    Open Access•Thim Prætorius, Pia Pinholt Munksgaard et al.•ARTICLE•International Journal of…•2022

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 2.913 (2021 JCR, received in June 2022)The IJIC 20th Anniversary Issue was published in 2021

  • Supporting the health and self-care among vulnerable citizens with diabetes

    Open Access•Sissel Due Jensen, Marie Ørts Rahbæk et al.•ARTICLE•International Journal of…•2022

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 2.913 (2021 JCR, received in June 2022)The IJIC 20th Anniversary Issue was published in 2021

No prominent works on this page.

  • Digitally Connecting Health Care Providers to Integrate Chronic Care

    Open Access•Thim Prætorius, Pia Pinholt Munksgaard et al.•ARTICLE•International Journal of…•2022

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 2.913 (2021 JCR, received in June 2022)The IJIC 20th Anniversary Issue was published in 2021

  • Supporting the health and self-care among vulnerable citizens with diabetes

    Open Access•Sissel Due Jensen, Marie Ørts Rahbæk et al.•ARTICLE•International Journal of…•2022

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 2.913 (2021 JCR, received in June 2022)The IJIC 20th Anniversary Issue was published in 2021

  • Beyond the prescription

    Open Access•Sissel Due Jensen, Bruno Gualano et al.•ARTICLE•PLOS Global Public Health•2025

    Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are transforming medicine globally. Given the efficacy and the demand for these drugs for weight loss, significant and complex social implications will follow. Drawing on our current qualitative studies with users in Brazil, Denmark, Japan, the United States, and online communities, alongside our pre-GLP-1RA studies in ten additional countries, we identify nine emerging global trends. These inc…

  • Tinkering with weight loss medication in clinical encounters

    Open Access•Sissel Due Jensen, Annelli Sandbæk et al.•ARTICLE•Social Science & Medicine•2025•References: 26

    The introduction of semaglutide, a glucagon-like-1 receptor agonist (GLP-1ra) as a weight-loss medication, has attracted considerable public and medical attention, reporting weight reductions of up to 15 %. However, its rapid adoption highlights the growing entanglement of the pharmaceutical industry, public health agendas, and cultural body ideals. This development calls for a closer examination of how such medications impact medical practices, …

Computer Science (2 works) · Medicine (2 works) · Obesity (2 works) · Obesity and Health Practices (2 works) · Weight loss (2 works) · Anthropology (1 work) · Bariatric Surgery and Outcomes (1 work) · Chronic Disease Management Strategies (1 work) · Diabetes Management and Education (1 work) · Diabetes Treatment and Management (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae